COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Safety of Transplantation of CRISPR CCR5 Modified CD34+ Cells in HIV-infected Subjects With Hematological Malignances

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03164135
Recruitment Status : Recruiting
First Posted : May 23, 2017
Last Update Posted : May 23, 2017
Peking University
Capital Medical University
Information provided by (Responsible Party):
Chen Hu, Affiliated Hospital to Academy of Military Medical Sciences

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 20, 2019
Estimated Study Completion Date : May 20, 2021